For research use only. Not for therapeutic Use.
Sapropterin dihydrochloride (CAT: I004598) is a synthetic form of tetrahydrobiopterin (BH4), a cofactor involved in the synthesis of neurotransmitters such as dopamine, serotonin, and norepinephrine. It is primarily used as a medication to treat phenylketonuria (PKU), a genetic disorder that impairs the body’s ability to process the amino acid phenylalanine. Sapropterin dihydrochloride helps increase the levels of functional BH4 in the body, thereby improving the metabolism of phenylalanine and reducing its buildup in individuals with PKU. By managing phenylalanine levels, sapropterin dihydrochloride can help prevent or minimize the neurological and cognitive complications associated with PKU.
Catalog Number | I004598 |
CAS Number | 69056-38-8 |
Synonyms | BH4 |
Molecular Formula | C9H15N5O3 • 2HCl |
Purity | ≥95% |
Target | Disease Research Fields |
Solubility | H2O: ≥ 34 mg/mL |
Storage | -20°C |
Overview of Clinical Research | <p> |
IUPAC Name | (6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one;dihydrochloride |
InChI | InChI=1S/C9H15N5O3.2ClH/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7;;/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17);2*1H/t3-,4+,6-;;/m0../s1 |
InChIKey | RKSUYBCOVNCALL-NTVURLEBSA-N |
SMILES | CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O.Cl.Cl |
Reference | <p style=”/line-height:25px/”> |